Elevated concentrations of morphine 6‐beta‐D‐glucuronide in brain extracellular fluid despite low blood–brain barrier permeability

No abstract is available for this paper.

• Publication year

  1999

• Venue

  British Journal of Pharmacology

• Publication date

  1999-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.bjp.0702873PMID 10556926PMCID PMC1571713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetic estimations from microdialysis data

  2006cited by this paper
• Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

  1999cited by this paper
• Simultaneous microdialysis in brain and blood of the mouse: extracellular and intracellular brain colchicine disposition.

  1998cited by this paper
• Intestinal absorption and stability of morphine 6-glucuronide in different physiological compartments of the rat.

  1998cited by this paper
• Mrp1 Multidrug Resistance‐Associated Protein and P‐Glycoprotein Expression in Rat Brain Microvessel Endothelial Cells

  1998cited by this paper
• Application of Microdialysis in Pharmacokinetic Studies

  1997cited by this paper
• Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine.

  1997cited by this paper
• Drug Equilibration Across the Blood—Brain Barrier-Pharmacokinetic Considerations Based on the Microdialysis Method

  1997cited by this paper
• Quantitative assessment of blood-brain barrier damage during microdialysis.

  1996cited by this paper
• Disposition and analgesic effects of systemic morphine, morphine-6-glucuronide and normorphine in rat.

  1996cited by this paper
• Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat.

  1996influential reference
• Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene

  1996cited by this paper
• Evidence for P‐glycoprotein‐modulated penetration of morphine‐6‐glucuronide into brain capillary endothelium

  1996cited by this paper
• Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow‐release oral morphine administration

  1995influential reference
• Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling.

  1995cited by this paper
• Cerebral uptake of morphine in the pig calculated from arterio-venous plasma concentration gradients: an alternative to tissue microdialysis.

  1995cited by this paper
• Plasma and Cerebrospinal Fluid Concentrations of Morphine and Morphine Glucuronides in Rabbits Receiving Single and Repeated Doses of Morphine

  1995cited by this paper
• Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.

  1995influential reference
• Diffusion of morphine-6-beta-D-glucuronide into the neonatal guinea pig brain during drug-induced respiratory depression.

  1994influential reference
• Plasma and Cerebrospinal Fluid Concentrations of Morphine and Morphine Glucuronides after Oral Morphine: The Influence of Renal Failure

  1994cited by this paper
• Concentrations of morphine, morphine‐6‐glucuronide and morphine‐3‐glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine‐resistant pain

  1994cited by this paper
• Morphine and morphine metabolite kinetics in the rat brain as assessed by transcortical microdialysis.

  1994cited by this paper
• Microdialysis Calibration Using Retrodialysis and Zero-Net Flux: Application to a Study of the Distribution of Zidovudine to Rabbit Cerebrospinal Fluid and Thalamus

  1993cited by this paper
• An improved extraction method for the HPLC determination of morphine and its metabolites in plasma.

  1993cited by this paper
• Time course of the distribution of morphine in brain regions, spinal cord and serum following intravenous injection to rats of differing ages.

  1993cited by this paper
• Uptake, 3-, and 6-glucuronidation of morphine in isolated cells from stomach, intestine, colon, and liver of the guinea pig.

  1993cited by this paper
• Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.

  1992cited by this paper
• The analgesic activity of morphine-6-glucuronide.

  1992cited by this paper
• Determination of in vivo steady-state unbound drug concentration in the brain interstitial fluid by microdialysis

  1992influential reference
• Simultaneous Measurement of Extracellular Morphine and Serotonin in Brain Tissue and CSF by Microdialysis in Awake Rats

  1992cited by this paper
• Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity.

  1991cited by this paper
• Quantitative Microdialysis: Analysis of Transients and Application to Pharmacokinetics in Brain

  1991cited by this paper
• The Extracellular Concentration of the Anti‐epileptic Drug Valproate in the Rat Brain as Determined with Microdialysis and an Automated HPLC Procedure

  1991cited by this paper
• Species difference of site-selective glucuronidation of morphine.

  1991cited by this paper
• Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide.

  1991influential reference
• Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine‐6‐glucuronide

  1990cited by this paper
• Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.

  1989influential reference
• Morphine-6-glucuronide has high affinity for the opioid receptor.

  1987cited by this paper
• Glucuronidation in vitro and in vivo. Comparison of intestinal and hepatic conjugation of morphine, naloxone, and buprenorphine.

  1987cited by this paper
• The rat brain in stereotaxic coordinates: Authors: George Paxinos & Charles Watson Academic Press Australia, 1982 Softback, 154 pages (including 71 plates), 35.00 Aust $

  1983influential reference
• Distributed model for drug delivery to CSF and brain tissue.

  1983cited by this paper
• Transport of sulfate in the rabbit's brain

  1973cited by this paper
• Biochemical basis for analgesic activity of morphine-6-glucuronide. I. Penetration of morphine-6-glucuronide in the brain of rats.

  1973cited by this paper
• Transport of sulfate in the rabbits brain.

  1973cited by this paper
• Analgesic effect of morphine glucuronides.

  1971cited by this paper
• Distribution of Blood (Fe59) and Plasma (I131) Volumes of Rats Determined by Liquid Nitrogen Freezing

  1956cited by this paper

• Non‐linear blood–brain barrier transport and dosing strategies influence receptor occupancy ratios of morphine and its metabolites in pain matrix

  2024cites this paper
• Heroin and its metabolites: relevance to heroin use disorder

  2023cites this paper
• The effect of morphine on rat microglial phagocytic activity: an in vitro study of brain region-, plating density-, sex-, morphine concentration-, and receptor-dependency

  2023cites this paper
• Peripherally restricted transthyretin-based delivery system for probes and therapeutics avoiding opioid-related side effects

  2022cites this paper
• Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model

  2022cites this paper
• Modeling Blood–Brain Barrier Permeability to Solutes and Drugs In Vivo

  2022cites this paper
• Preliminary study of the pharmacokinetics, tissue distribution, and behavioral and select physiological effects of morphine 6-glucuronide (M6G) following intravenous administration to horses.

  2022cites this paper
• Application of a high‐resolution in vitro human MDR1‐MDCK assay and in vivo studies in preclinical species to improve prediction of CNS drug penetration

  2022cites this paper
• Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species Differences.

  2021cites this paper
• A Practical Perspective on the Evaluation of Small Molecule CNS Penetration in Drug Discovery.

  2020cites this paper
• Use of Intravenous Infusion Study Design to Simultaneously Determine Brain Penetration and Systemic Pharmacokinetic Parameters in Rats

  2020cites this paper
• Synthesis and Biological Characterization of Cyclic Disulfide-Containing Peptide Analogs of the Multifunctional Opioid/Neuropeptide FF Receptor Agonists That Produce Long-Lasting and Nontolerant Antinociception.

  2020cites this paper
• Metabolism of IMM-H004 and Its Pharmacokinetic-Pharmacodynamic Analysis in Cerebral Ischemia/Reperfusion Injured Rats

  2019cites this paper
• Computational framework for predictive PBPK-PD-Tox simulations of opioids and antidotes

  2019cites this paper
• THE BRAIN EXPOSURE EFFICIENCY (BEE) SCORE.

  2019cites this paper
• Morphine Binds Creatine Kinase B and Inhibits Its Activity

  2018cites this paper
• Opioids and the Blood-Brain Barrier: A Dynamic Interaction with 
Consequences on Drug Disposition in Brain

  2017cites this paper
• Diurnal variation in the pharmacokinetics and brain distribution of morphine and its major metabolite

  2017cites this paper
• Effect of Subchronic Intravenous Morphine Infusion and Naloxone-Precipitated Morphine Withdrawal on P-gp and Bcrp at the Rat Blood-Brain Barrier.

  2016cites this paper
• [Drug glucuronidation and disposition in brain].

  2016cites this paper
• Sugar Derivatives of Morphine: A New Window for the Development of Potent Anesthetic Drugs

  2015cites this paper
• CNS drug design: balancing physicochemical properties for optimal brain exposure.

  2015cites this paper
• A review of morphine and morphine-6-glucuronide's pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain.

  2015cites this paper
• PKPD Aspects of Brain Drug Delivery in a Translational Perspective

  2014cites this paper
• Blood–Brain Barrier Permeability and Brain Uptake Mechanism of Kainic Acid and Dihydrokainic Acid

  2014cites this paper
• Utility of CSF in translational neuroscience

  2013cites this paper
• In vitro morphine metabolism by rat microglia.

  2013cites this paper
• Effect of 12‐oxochenodeoxycholate on the pharmacokinetics and pharmacodynamics of morphine 6‐glucuronide in Wistar rats

  2013cites this paper
• Utility of CSF in translational neuroscience

  2013cites this paper
• Surgery‐induced inflammation reduces morphine distribution into cerebrospinal fluid

  2013cites this paper
• Translational Approaches for Predicting CNS Drug Effects Using Microdialysis

  2013cites this paper
• Erratum to: Induction of morphine-6-glucuronide synthesis by heroin self-administration in the rat

  2012influential citation
• Induction of morphine-6-glucuronide synthesis by heroin self-administration in the rat

  2012cites this paper
• CNS Penetration of Tyrosine Kinase Inhibitors in Mouse Models

  2012cites this paper
• Permeability: Blood–Brain Barrier

  2012cites this paper
• The distribution of opiates, cocaine and their metabolites in skeletal muscle tissue and vitreous humour as an aid to post-mortem toxicological interpretation

  2011cites this paper
• How to measure drug transport across the blood-brain barrier

  2011cites this paper
• Effect of bile salts on the transport of morphine-6-glucuronide in rat brain endothelial cells.

  2011cites this paper
• Effect of bile salts on drug delivery to the brain

  2010cites this paper
• Strong opioids in cancer pain : clinical and pharmacogenetic factors influencing an individual's response to morphine and oxycodone

  2010cites this paper
• Role of ATP-Binding Cassette and Solute Carrier Transporters in Erlotinib CNS Penetration and Intracellular Accumulation

  2010cites this paper
• Addressing Central Nervous System (CNS) Penetration in Drug Discovery: Basics and Implications of the Evolving New Concept

  2009cites this paper
• Can Heterogeneity of Chronic Sickle-Cell Disease Pain Be Explained by Genomics? A Literature Review

  2009cites this paper
• Methodologies to assess brain drug delivery in lead optimization.

  2009cites this paper
• Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid.

  2009cites this paper
• Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid

  2009cites this paper
• Differential Effect of Morphine and Morphine-6-glucuronide on the Control of Breathing in the Anesthetized Cat

  2008cites this paper
• Different time schedules affect conditioned place preference after morphine and morphine-6-glucuronide administration.

  2008influential citation
• The use of a deuterated calibrator for in vivo recovery estimations in microdialysis studies.

  2008cites this paper
• Morphine‐6‐glucuronide (M6G) for postoperative pain relief

  2008cites this paper
• Factors Influencing Topotecan CNS Penetration in Mouse Models

  2008cites this paper
• Comparative measurement of spinal CSF microdialysate concentrations and concomitant antinociception of morphine and morphine-6beta-glucuronide in rats.

  2007cites this paper
• Morphine in Children with Cancer

  2007cites this paper
• Central Nervous System Pharmacokinetics of the Mdr1 P-Glycoprotein Substrate CP-615,003: Intersite Differences and Implications for Human Receptor Occupancy Projections from Cerebrospinal Fluid Exposures

  2007influential citation
• A Randomized, Double-blind, Placebo-controlled Pilot Study of IV Morphine-6-Glucuronide for Postoperative Pain Relief After Knee Replacement Surgery

  2007cites this paper
• Synthesis and pharmacological analysis of a morphine/substance P chimeric molecule with full analgesic potency in morphine-tolerant rats.

  2007cites this paper
• CNS PHARMACOKINETICS OF THE MDR1 P-GLYCOPROTEIN SUBSTRATE CP- 615,003: INTER-SITE DIFFERENCES AND IMPLICATIONS FOR HUMAN RECEPTOR OCCUPANCY PROJECTIONS FROM CSF EXPOSURES

  2007cites this paper
• On The Rate and Extent of Drug Delivery to the Brain

  2007cites this paper
• Different effects of morphine and morphine-6beta-glucuronide on formalin-evoked spinal glutamate release in conscious and freely moving rats.

  2007cites this paper
• Cholestasis and Endogenous Opioids

  2007cites this paper
• Evaluation of Cerebrospinal Fluid Concentration and Plasma Free Concentration As a Surrogate Measurement for Brain Free Concentration

  2006cites this paper
• Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-beta-D-glucuronide.

  2006cites this paper
• Blood–brain distribution of morphine‐6‐glucuronide in sheep

  2006influential citation
• Distribution – in vivo – Other Methods

  2006cites this paper
• Chapter 6.4 Microdialysis as a method to study blood-brain barrier transport mechanisms

  2006cites this paper
• Chapter 6.6 Microdialysis for characterization of PK/PD relationships

  2006cites this paper
• Morphine-6-Glucuronide: Morphine's Successor for Postoperative Pain Relief?

  2006cites this paper
• Tissue distribution and pharmacodynamics: a complicated relationship.

  2006cites this paper
• Synthesis of an estradiol glucuronide derivative and investigation of its radiopharmaceutical potential.

  2006cites this paper
• Improved Brain Uptake and Pharmacological Activity Profile of Morphine-6-Glucuronide Using a Peptide Vector-Mediated Strategy

  2005cites this paper
• Morphine‐6‐glucuronide: Actions and mechanisms

  2005influential citation
• HPLC with laser-induced native fluorescence detection for morphine and morphine glucuronides from blood after immunoaffinity extraction

  2005cites this paper
• Randomized, Double-blind Study of the Analgesic Efficacy of Morphine-6-Glucuronide versus Morphine Sulfate for Postoperative Pain in Major Surgery

  2005cites this paper
• Dynamic medicinal chemistry in the elaboration of morphine-6-glucuronide analogs.

  2005cites this paper
• Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics.

  2004cites this paper
• Altered brain exposure of morphine in experimental meningitis studied with microdialysis

  2004cites this paper
• Blood-brain barrier transport of morphine in patients with severe brain trauma.

  2004cites this paper
• The potential of nasal application for delivery to the central brain-a microdialysis study of fluorescein in rats.

  2004cites this paper
• Relationships among morphine metabolism, pain and side effects during long-term treatment: an update.

  2003cites this paper
• Pharmacodynamic Effect of Morphine-6-glucuronide versus Morphine on Hypoxic and Hypercapnic Breathing in Healthy Volunteers

  2003cites this paper
• Different distribution of morphine and morphine‐6β‐glucuronide after intracerebroventricular injection in rats

  2003cites this paper
• Hydrophobic forms of morphine-6-glucosides.

  2001cites this paper
• Morphine-6-Glucuronide

  2001cites this paper
• Blood‐brain barrier transport and brain distribution of morphine‐6‐glucuronide in relation to the antinociceptive effect in rats – pharmacokinetic/pharmacodynamic modelling

  2001influential citation
• The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics.

  2000cites this paper
• In vivo microdialysis as a tool for monitoring pharmacokinetics

  2000cites this paper